Hikma patent expiration

1. Combogesic Iv patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11896567 HIKMA Combination composition
Oct, 2031

(7 years from now)

US11446266 HIKMA Combination composition
Oct, 2031

(7 years from now)

US11389416 HIKMA Aqueous formulation comprising paracetamol and ibuprofen
Jul, 2035

(11 years from now)

US11213498 HIKMA Aqueous formulation comprising paracetamol and ibuprofen
Jan, 2036

(11 years from now)




Drug Exclusivity Drug Exclusivity Expiration
New Product(NP) Oct 17, 2026

Drugs and Companies using ACETAMINOPHEN; IBUPROFEN SODIUM ingredient

Market Authorisation Date: 17 October, 2023

Treatment: Method of treating moderate to severe pain in adults as an adjunct to opioid analgesics

Dosage: SOLUTION

More Information on Dosage

COMBOGESIC IV family patents

Family Patents

2. Immphentiv patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11471400 HIKMA Phenylephrine hydrochloride ready-to-use solution
Aug, 2036

(12 years from now)

US11213480 HIKMA Phenylephrine hydrochloride ready-to-use solution
Sep, 2036

(12 years from now)




Drugs and Companies using PHENYLEPHRINE HYDROCHLORIDE ingredient

Market Authorisation Date: 09 March, 2023

Treatment: NA

Dosage: SOLUTION

More Information on Dosage

IMMPHENTIV family patents

Family Patents

Stay ahead of others in designing the generic launch strategy of these 5 blockbuster drugs expiring in next 5 years.

Get the exclusive patent insights now. Don't be the last to know.

3. Kloxxado patent expiration

Can you believe KLOXXADO received compensation for the extended wait time during the regulatory approval process?
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11628139 HIKMA Liquid naloxone spray
Aug, 2034

(10 years from now)

US10973814 HIKMA Liquid naloxone spray
Aug, 2034

(10 years from now)

US10722510 HIKMA Liquid naloxone spray
Aug, 2034

(10 years from now)

US11135155 HIKMA Liquid naloxone spray
Aug, 2034

(10 years from now)

US11617713 HIKMA Liquid naloxone spray
Aug, 2034

(10 years from now)




Drug Exclusivity Drug Exclusivity Expiration
New Product(NP) Apr 29, 2024

Drugs and Companies using NALOXONE HYDROCHLORIDE ingredient

Market Authorisation Date: 29 April, 2021

Treatment: Use of naloxone for the emergency treatment of known or suspected opioid overdose, as manifested by respiratory and/or central nervous system depression, for adult and pediatric patients

Dosage: SPRAY

How can I launch a generic of KLOXXADO before it's drug patent expiration?
More Information on Dosage

KLOXXADO family patents

Family Patents

4. Levothyroxine Sodium patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11154498 HIKMA Stabilized liquid formulation of levothyroxine
Jul, 2036

(12 years from now)




Drugs and Companies using LEVOTHYROXINE SODIUM ingredient

Market Authorisation Date: 17 May, 2021

Treatment: NA

Dosage: SOLUTION

How can I launch a generic of LEVOTHYROXINE SODIUM before it's drug patent expiration?
More Information on Dosage

LEVOTHYROXINE SODIUM family patents

Family Patents

5. Xopenex patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5362755 HIKMA Method for treating asthma using optically pure (R)-albuterol
Mar, 2013

(11 years ago)

US5547994 HIKMA Method for treating asthma using optically pure R(-) albuterol
Aug, 2013

(10 years ago)

US6451289 HIKMA Albuterol formulations
Mar, 2021

(3 years ago)




Drug Exclusivity Drug Exclusivity Expiration
M(M-151) Jan 22, 2018

Drugs and Companies using LEVALBUTEROL HYDROCHLORIDE ingredient

Market Authorisation Date: 30 January, 2002

Treatment: Treatment or prevention of bronchospasm

Dosage: SOLUTION

How can I launch a generic of XOPENEX before it's drug patent expiration?
More Information on Dosage

XOPENEX family patents

Family Patents